Annual Shareholders Equity
$20.78 M
+$1.25 M+6.40%
31 December 2023
Summary:
Oncolytics Biotech annual stockholders equity is currently $20.78 million, with the most recent change of +$1.25 million (+6.40%) on 31 December 2023. During the last 3 years, it has risen by +$1.37 million (+7.03%). ONCY annual shareholders equity is now -50.44% below its all-time high of $41.93 million, reached on 31 December 2010.ONCY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$6.70 M
-$6.67 M-49.86%
30 September 2024
Summary:
Oncolytics Biotech quarterly stockholders equity is currently $6.70 million, with the most recent change of -$6.67 million (-49.86%) on 30 September 2024. Over the past year, it has dropped by -$14.64 million (-68.60%). ONCY quarterly shareholders equity is now -87.62% below its all-time high of $54.13 million, reached on 31 March 2011.ONCY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.4% | -68.6% |
| 3 y3 years | +7.0% | -80.0% |
| 5 y5 years | +356.8% | +157.1% |
ONCY Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.6% | +7.0% | -80.0% | at low |
| 5 y | 5 years | -26.6% | >+9999.0% | -82.1% | +8215.6% |
| alltime | all time | -50.4% | >+9999.0% | -87.6% | +8215.6% |
Oncolytics Biotech Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.70 M(-49.9%) |
| June 2024 | - | $13.37 M(-21.4%) |
| Mar 2024 | - | $17.00 M(-18.2%) |
| Dec 2023 | $20.78 M(+6.4%) | $20.78 M(-2.7%) |
| Sept 2023 | - | $21.35 M(+27.2%) |
| June 2023 | - | $16.78 M(-11.9%) |
| Mar 2023 | - | $19.04 M(-2.5%) |
| Dec 2022 | $19.53 M(-31.0%) | $19.53 M(-6.0%) |
| Sept 2022 | - | $20.76 M(-13.1%) |
| June 2022 | - | $23.88 M(-14.8%) |
| Mar 2022 | - | $28.05 M(-0.9%) |
| Dec 2021 | $28.31 M(+45.9%) | $28.31 M(-15.4%) |
| Sept 2021 | - | $33.49 M(-10.7%) |
| June 2021 | - | $37.49 M(+5.9%) |
| Mar 2021 | - | $35.39 M(+82.3%) |
| Dec 2020 | $19.41 M(<-9900.0%) | $19.41 M(+23.9%) |
| Sept 2020 | - | $15.67 M(-10.8%) |
| June 2020 | - | $17.56 M(+6.3%) |
| Mar 2020 | - | $16.52 M(<-9900.0%) |
| Dec 2019 | -$82.60 K(-101.8%) | -$82.60 K(-103.2%) |
| Sept 2019 | - | $2.61 M(-9.6%) |
| June 2019 | - | $2.89 M(-32.4%) |
| Mar 2019 | - | $4.27 M(-6.1%) |
| Dec 2018 | $4.55 M(-31.0%) | $4.55 M(-35.1%) |
| Sept 2018 | - | $7.00 M(-15.3%) |
| June 2018 | - | $8.27 M(+125.2%) |
| Mar 2018 | - | $3.67 M(-44.2%) |
| Dec 2017 | $6.59 M(-16.9%) | $6.59 M(-32.1%) |
| Sept 2017 | - | $9.70 M(-11.6%) |
| June 2017 | - | $10.97 M(+101.1%) |
| Mar 2017 | - | $5.45 M(-31.2%) |
| Dec 2016 | $7.93 M(-55.4%) | $7.93 M(-33.3%) |
| Sept 2016 | - | $11.89 M(-17.3%) |
| June 2016 | - | $14.37 M(-8.9%) |
| Mar 2016 | - | $15.77 M(-11.3%) |
| Dec 2015 | $17.78 M(+49.4%) | $17.78 M(-13.9%) |
| Sept 2015 | - | $20.65 M(-14.9%) |
| June 2015 | - | $24.27 M(+13.3%) |
| Mar 2015 | - | $21.43 M(+80.0%) |
| Dec 2014 | $11.90 M(-42.9%) | $11.90 M(-10.1%) |
| Sept 2014 | - | $13.24 M(-13.8%) |
| June 2014 | - | $15.35 M(-6.8%) |
| Mar 2014 | - | $16.47 M(-21.1%) |
| Dec 2013 | $20.86 M(+40.4%) | $20.86 M(-22.1%) |
| Sept 2013 | - | $26.79 M(-17.0%) |
| June 2013 | - | $32.29 M(-15.1%) |
| Mar 2013 | - | $38.03 M(+155.9%) |
| Dec 2012 | $14.86 M | $14.86 M(-34.8%) |
| Sept 2012 | - | $22.81 M(-25.6%) |
| June 2012 | - | $30.65 M(-26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $41.43 M(+43.3%) |
| Dec 2011 | $28.92 M(-31.0%) | $28.92 M(-24.2%) |
| Sept 2011 | - | $38.14 M(-18.8%) |
| June 2011 | - | $46.98 M(-13.2%) |
| Mar 2011 | - | $54.13 M(+29.1%) |
| Dec 2010 | $41.93 M(+40.8%) | $41.93 M(+124.0%) |
| Sept 2010 | - | $18.72 M(-13.2%) |
| June 2010 | - | $21.57 M(-19.5%) |
| Mar 2010 | - | $26.80 M(-10.0%) |
| Dec 2009 | $29.77 M(+288.0%) | $29.77 M(+346.7%) |
| Sept 2009 | - | $6.66 M(-18.7%) |
| June 2009 | - | $8.20 M(+87.2%) |
| Mar 2009 | - | $4.38 M(-42.9%) |
| Dec 2008 | $7.67 M(-67.4%) | $7.67 M(-24.0%) |
| Sept 2008 | - | $10.10 M(-30.7%) |
| June 2008 | - | $14.57 M(-39.4%) |
| Mar 2008 | - | $24.03 M(+2.2%) |
| Dec 2007 | $23.52 M(-10.9%) | $23.52 M(-26.1%) |
| Sept 2007 | - | $31.81 M(-4.1%) |
| June 2007 | - | $33.17 M(-1.7%) |
| Mar 2007 | - | $33.73 M(+27.7%) |
| Dec 2006 | $26.41 M(-31.0%) | $26.41 M(-16.8%) |
| Sept 2006 | - | $31.75 M(-8.6%) |
| June 2006 | - | $34.73 M(-2.2%) |
| Mar 2006 | - | $35.52 M(-7.1%) |
| Dec 2005 | $38.25 M(+19.7%) | $38.25 M(+16.3%) |
| Sept 2005 | - | $32.89 M(+10.8%) |
| June 2005 | - | $29.69 M(-8.1%) |
| Mar 2005 | - | $32.31 M(+1.1%) |
| Dec 2004 | $31.94 M(+65.8%) | $31.94 M(+44.2%) |
| Sept 2004 | - | $22.15 M(-2.0%) |
| June 2004 | - | $22.61 M(+27.2%) |
| Mar 2004 | - | $17.77 M(-7.7%) |
| Dec 2003 | $19.26 M(+83.6%) | $19.26 M(+26.7%) |
| Sept 2003 | - | $15.20 M(+14.6%) |
| June 2003 | - | $13.27 M(+24.5%) |
| Mar 2003 | - | $10.66 M(+1.6%) |
| Dec 2002 | $10.49 M(+5.0%) | $10.49 M(+1.8%) |
| Sept 2002 | - | $10.31 M(-14.9%) |
| June 2002 | - | $12.12 M(+31.8%) |
| Mar 2002 | - | $9.20 M(-7.9%) |
| Dec 2001 | $9.99 M(-24.7%) | $9.99 M(-6.0%) |
| Sept 2001 | - | $10.63 M(-13.6%) |
| June 2001 | - | $12.30 M(-0.4%) |
| Mar 2001 | - | $12.35 M(-6.9%) |
| Dec 2000 | $13.27 M(+178.5%) | $13.27 M(-1.7%) |
| Sept 2000 | - | $13.50 M(+6.8%) |
| June 2000 | - | $12.65 M(-8.2%) |
| Mar 2000 | - | $13.78 M |
| Dec 1999 | $4.76 M | - |
FAQ
- What is Oncolytics Biotech annual stockholders equity?
- What is the all time high annual shareholders equity for Oncolytics Biotech?
- What is Oncolytics Biotech annual shareholders equity year-on-year change?
- What is Oncolytics Biotech quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly shareholders equity year-on-year change?
What is Oncolytics Biotech annual stockholders equity?
The current annual shareholders equity of ONCY is $20.78 M
What is the all time high annual shareholders equity for Oncolytics Biotech?
Oncolytics Biotech all-time high annual stockholders equity is $41.93 M
What is Oncolytics Biotech annual shareholders equity year-on-year change?
Over the past year, ONCY annual stockholders equity has changed by +$1.25 M (+6.40%)
What is Oncolytics Biotech quarterly stockholders equity?
The current quarterly shareholders equity of ONCY is $6.70 M
What is the all time high quarterly shareholders equity for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly stockholders equity is $54.13 M
What is Oncolytics Biotech quarterly shareholders equity year-on-year change?
Over the past year, ONCY quarterly stockholders equity has changed by -$14.64 M (-68.60%)